| Literature DB >> 33936350 |
Yavuz Orak1, Fatma İnanç Tolun2, Murat Bakacak3, Aslı Yaylalı4, Hakan Kıran3, Hafize Öksüz1, Adem Doğaner5, Işıl Yağmur2, Ahmet Altun6.
Abstract
Background: Pain aggravates the autonomic response to stress and raises neuroendocrine stress hormone levels. We compared the effects of propofol and sevoflurane on postoperative pain and neuroendocrine stress hormones. A prospective, randomized, and controlled trial was conducted with 60 patients.Entities:
Mesh:
Substances:
Year: 2021 PMID: 33936350 PMCID: PMC8055426 DOI: 10.1155/2021/5517150
Source DB: PubMed Journal: Pain Res Manag ISSN: 1203-6765 Impact factor: 3.037
Figure 1The CONSORT flow diagram of groups. CONSORT: Consolidated Standards of Reporting Trials. Group P: propofol + remifentanil. Group S: sevoflurane + remifentanil.
Sociodemographic and clinical data of patients.
| Group P ( | Group S ( | Statistics |
| ||
|---|---|---|---|---|---|
| Age | Mean ± SD | 31,87 ± 5,26 | 33,97 ± 5,10 | 1,570a | 0,122 |
| BMI | Mean ± SD | 25,81 ± 3,59 | 26,55 ± 4,75 | 0,678a | 0,501 |
| Operation time | Median (Q1–Q3) | 10,00 (10,00–15,00) | 10,00 (7,00–15,00) | 414,500b | 0,579 |
| PAAR | Median (Q1–Q3) | 2,00 (2,00–2,00) | 2,00 (1,00–2,00) | 416,500b | 0,710 |
| IRD | Median (Q1–Q3) | 35,00 (30,00–40,00) | 35,00 (30,00–40,00) | 412,500b | 0,567 |
| IPD | Median (Q1–Q3) | 70,00 (60,00–80,00) | |||
| ARRDO | Median (Q1–Q3) | 20,00 (20,00–40,00) | 0,000,00–0,00) | 167,000b |
|
| APRDO | Median (Q1 Q3) | 60,00 (40,00 80,00) | |||
| VAS 1st.dk | Median (Q1–Q3) | 2,00 (1,00–4,00) | 2,00 (0,00–3,00) | 322,500b | 0,054 |
| VAS 5th min | Median (Q1–Q3) | 2,00 (1,00–4,00) | 2,00 (0,00–4,00) | 369,000b | 0,224 |
| VAS 15th min | Median (Q1–Q3) | 2,00 (1,00–4,00) | 2,00 (0,00–3,00) | 359,000b | 0,171 |
| VAS 30th min | Median (Q1–Q3) | 2,00 (1,00–5,00) | 2,00 (1,00–4,00) | 406,500b | 0,661 |
| VAS 60th min | Median (Q1–Q3) | 2,00 (1,00–3,00) | 2,00 (0,00–4,00) | 416,000b | 0,609 |
aIndependent samples t-test. bMann–Whitney U test. α = .05. Statistically significant difference. Postoperative additional analgesic requirement: PAAR. Additional remifentanil requirement during operation: ARRDO. Additional propofol requirement during operation: APRDO. Induction remifentanil dose: IRD. Induction propofol dose: IPD.
Between-group and intragroup comparisons of blood parameters between groups P and S.
| Group P | Group S |
| ||
|---|---|---|---|---|
| ( | ( | |||
| ACTH (pg/mL) | Preoperative | 136,15 ± 8,11 | 137,93 ± 11,35 | 0,487 |
| Postoperative | 140,81 ± 6,85 | 138,55 ± 11,52 | 0,359 | |
| Pa |
| 0,859 | ||
|
| ||||
| Aldosterone (pg/mL) | Preoperative | 37,98 ± 16,14 | 23,78 ± 15,75 |
|
| Postoperative | 37,94 ± 14,30 | 36,05 ± 18,79 | 0,663 | |
| Pa | 0,985 |
| ||
|
| ||||
| CRH (pg/mL) | Preoperative | 11,89 ± 1,51 | 11,25 ± 1,18 | 0,073 |
| Postoperative | 11,93 ± 1,01 | 12,23 ± 1,01 | 0,254 | |
| Pa | 0,884 |
| ||
|
| ||||
| Glucagon (pg/mL) | Preoperative | 104,52 ± 4,92 | 104,79 ± 18,77 | 0,940 |
| Postoperative | 107,50 ± 3,93 | 103,60 ± 7,89 |
| |
| Pa |
| 0,761 | ||
|
| ||||
| Cortisol (ng/mL) | Preoperative | 146,02 ± 32,63 | 137,15 ± 35,77 | 0,320 |
| Postoperative | 129,20 ± 35,45 | 138,07 ± 39,74 | 0,365 | |
| Pa |
| 0,924 | ||
|
| ||||
| PG E2 (ng/mL) | Preoperative | 34,67(30,65–51,68) | 33,99(32,35–37,43) | 0,802b |
| Postoperative | 42,50(34,17–102,87) | 33,50(31,15–40,83) |
| |
| Pc |
| 0,644 | ||
Independent samples t-test; apaired t-test; bMann–Whitney U test; cWilcoxon test; a: 0.05; statistically significant. ACTH, adrenocorticotropic hormone; CRH, corticotropin-releasing hormone; and PGE2, prostaglandin E2.
Comparison of follicular fluid levels between groups P and S.
| Follicle | Group P ( | Group S ( |
|
|---|---|---|---|
| ACTH (pg/mL) | 137,76 ± 14,26 | 142,39 ± 20,94 | 0,329 |
| Aldosterone (pg/mL) | 84,91 ± 19,48 | 88,67 ± 9,09 | 0,363 |
| CRH (pg/mL) | 10,85 ± 2,38 | 11,79 ± 1,38 | 0,078 |
| Glucagon (pg/mL) | 99,53 ± 6,88 | 87,37 ± 15,99 |
|
| Cortisol (ng/mL) | 92,49 ± 44,23 | 122,31 ± 35,68 |
|
| PGE 2 (ng/mL) | 69,52 (46,59–156,84) | 32,74 (26,71–39,18) |
|
Independent samples t-test; aMann–Whitney U test; α: 0.05; statistically significant. ACTH, adrenocorticotropic hormone; CRH, corticotropin-releasing hormone; and PGE2, prostaglandin E2.
Preoperative correlation analysis of blood variables between groups.
| ACTH (pg/mL) | CRH (pg/mL) | Glucagon (pg/mL) | |||||
|---|---|---|---|---|---|---|---|
| Preoperative correlation | r | p | r | p | r | p | |
| Group P | CRH (pg/mL) | −0,322 | 0,082 | ||||
| Glucagon (pg/mL) | 0,269 | 0,150 | −0,402 |
| |||
| Cortisol (ng/mL) | 0,105 | 0,580 | −0,211 | 0,262 | 0,134 | 0,480 | |
|
| |||||||
| Group S | CRH (pg/mL) | 0,017 | 0,927 | ||||
| Glucagon (pg/mL) | −0,069 | 0,716 | −0,155 | 0,414 | |||
| Cortisol (ng/mL) | 0,336 | 0,069 | 0,067 | 0,724 | 0,145 | 0,445 | |
aPearson correlation test; α: 0.05. Statistical significance. CRH: corticotropin-releasing hormone and ACTH: adrenocorticotropic hormone.
Postoperative correlation analysis of blood variables between groups.
| ACTH (pg/mL) | CRH (pg/mL) | Glucagon (pg/mL) | |||||
|---|---|---|---|---|---|---|---|
| Postoperative correlation | r | p | r | p | r | p | |
| Group P | CRH (pg/mL) | −0,084 | 0,659 | ||||
| Glucagon (pg/mL) | 0,317 | 0,088 | −0,014 | 0,942 | |||
| Cortisol (ng/mL) | −0,021 | 0,911 | 0,061 | 0,748 | −0,023 | 0,905 | |
|
| |||||||
| Group S | CRH (pg/mL) | −0,174 | 0,357 | ||||
| Glucagon (pg/mL) | 0,067 | 0,727 | −0,023 | 0,905 | |||
| Cortisol (ng/mL) | 0,149 | 0,433 | 0,429 |
| −0,080 | 0,673 | |
Pearson correlation test; α:0.05. Statistical significance. CRH: corticotropin-releasing hormone and ACTH: adrenocorticotropic hormone.
Correlation analysis of postoperative follicular fluids between groups.
| Follicular fluid | ACTH (pg/mL) | CRH (pg/mL) | Glucagon (pg/mL) | ||||
|---|---|---|---|---|---|---|---|
| r | p | r | p | r | p | ||
| Group P | CRH (pg/mL) | 0,248 | 0,187 | ||||
| Glucagon (pg/mL) | 0,243 | 0,196 | 0,161 | 0,396 | |||
| Cortisol (ng/mL) | 0,337 | 0,069 | 0,114 | 0,550 | 0,507 |
| |
|
| |||||||
| Group S | CRH (pg/mL) | −0,024 | 0,906 | ||||
| Glucagon (pg/mL) | 0,060 | 0,766 | 0,505 |
| |||
| Cortisol (ng/mL) | −0,064 | 0,750 | -0,291 | 0,140 | -0,028 | 0,891 | |
Pearson correlation test; α: 0.05. Statistical significance. CRH: corticotropin-releasing hormone and ACTH: adrenocorticotropic hormone.
Evaluation of intraoperative movements.
| Group P | Group S | ||||||
|---|---|---|---|---|---|---|---|
|
| % |
| % |
|
| ||
| Grade 0 | No | 8 | 26,7 | 25 | 83,3 | 19,461 |
|
| Yes | 22 | 73,3 | 5 | 16,7 | |||
|
| |||||||
| Grade 1 | No | 10 | 33,3 | 26 | 86,7 | 17,778 |
|
| Yes | 20 | 66,7 | 4 | 13,3 | |||
|
| |||||||
| Grade 2 | No | 14 | 46,7 | 26 | 86,7 | 10,800 |
|
| Yes | 16 | 53,3 | 4 | 13,3 | |||
|
| |||||||
| Grade 3 | No | 15 | 53,6 | 27 | 93,1 | 11,557 |
|
| Yes | 13 | 46,4 | 2 | 6,9 | |||
|
| |||||||
| Grade 4 | No | 15 | 50 | 26 | 86,7 | 9,319 |
|
| Yes | 15 | 50 | 4 | 13,3 | |||
Chi-square test, Fisher's exact test,α = .05. Significant relationship between groups. No: body movement none. Yes: there is body movement.
Figure 2Between-group comparison of the HR postoperatively. HR: heart rate.